On December 23, 2019 WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open access technology platform for biologics, the all-in-one solution for research, development and manufacturing offers biological preparations, reported the "Special Award to Investors in Ireland " at the Asia Matters Global Business Summit 2019 (Press release, WuXi Biologics, DEC 23, 2019, View Source [SID1234552594]). This is Ireland’s only Asian think tank that specifically deals with trade, investment and economic issues, as well as international relations between the EU and Asia.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The "Special Award to Investors in Ireland " is given to a newly established company that invests in Ireland. The emphasis is on a long-term and significant contribution to economic growth, employment, research and corporate social responsibility (CSR). Last year, WuXi Biologics a "Factory of the Future" for the production of biologicals was built in Dundalk. A second investment was announced last month by its subsidiary WuXi Vaccines. A new vaccine production facility is to be built at the Dundalk site.

"We are extremely pleased to receive this award from Asia Matters . It demonstrates the great progress we are making in Ireland, "said Dr. Chris Chen , CEO of WuXi Biologics, speaking at the summit." Based on our leading expertise and expertise in the high-growth biology business, we will continue to be our local and global partners provide a robust and world-class supply chain for the benefit of patients around the world. "